ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen " Will SynCardia's Emperor be capable of boldly going where no artificial heart has gone before? "
Episode Synopsis
In this week’s episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker talks with SynCardia CEO Patrick Schnegelsberg and COO Matthew Schuster. Twenty years after FDA approval, SynCardia is the only company with a commercially available total artificial heart, with more than 2,000 implants. Now they're developing what they think will be a game-changer for the technology: a next-gen artificial heart called the Emperor that will be a fully implantable version, without external drivers.
But before the interview Host Tom Salemi gives a quick recap of the MassMedic Symposium and Gala. Then, Chris Newmarker and Senior Editor Danielle Kirsh unpack MassDevice’s new report on surgical robotic companies.
You can download the report for free here. https://www.massdevice.com/gated/massdevices-surgical-robotics-special-report-2025/
Thanks for listening to the DeviceTalks Weekly Podcast.
Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
More episodes of the podcast DeviceTalks Podcast Network
Ray Cohen on How to Successfully Build and Exit a MedTech; Talking Revolution with Sarah Matt, MD
12/12/2025
How Enovis is unlocking better bracing with innovative materials, patient comfort & next-gen tech
09/12/2025
How amazing tech – like Medtronic’s LINQ and beyond – can, will and must change health care
05/12/2025
Where is surgical robotics headed? Listen to these leaders- Moon’s Osdoit, Intuitive’s Jeddi
26/11/2025
J&J’s Schmid, Stanford’s Makower on helping MedTech find a higher gear for innovation and growth
21/11/2025
How Enovis is accelerating orthopedic recovery with bone stimulation and patient-centered innovation
18/11/2025
Noah Medical’s clear vision for pulmonary bronchoscopy; FOMO: The true costs of MedTech tariffs
14/11/2025
In God we trust